CCH FEVER
"Crimean Congo Hemorrhagic Fever; Modern Approaches to Diagnostics, Surveillance, Prevention, Therapy and Preparedness."
| Coordinatore | FOLKHALSOMYNDIGHETEN
Organization address
address: NOBELS VAG 18 contact info |
| Nazionalità Coordinatore | Sweden [SE] |
| Sito del progetto | http://www.cch-fever.eu/ |
| Totale costo | 3˙849˙249 € |
| EC contributo | 3˙000˙000 € |
| Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
| Code Call | FP7-HEALTH-2010-single-stage |
| Funding Scheme | CP-FP |
| Anno di inizio | 2010 |
| Periodo (anno-mese-giorno) | 2010-10-01 - 2015-03-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
FOLKHALSOMYNDIGHETEN
Organization address
address: NOBELS VAG 18 contact info |
SE (SOLNA) | coordinator | 0.00 |
| 2 |
SMITTSKYDDSINSTITUTET
Organization address
address: Nobels vaeg 18 contact info |
SE (SOLNA) | participant | 533˙625.10 |
| 3 |
PHILIPPS UNIVERSITAET MARBURG
Organization address
address: Biegenstrasse 10 contact info |
DE (MARBURG) | participant | 417˙617.38 |
| 4 |
UNIVERSITAETSMEDIZIN GOETTINGEN - GEORG-AUGUST-UNIVERSITAET GOETTINGEN - STIFTUNG OEFFENTLICHEN RECHTS
Organization address
address: Robert-Koch-Strasse 40 contact info |
DE (GOETTINGEN) | participant | 320˙515.66 |
| 5 |
ARISTOTELIO PANEPISTIMIO THESSALONIKIS
Organization address
address: Administration Building, University Campus contact info |
EL (THESSALONIKI) | participant | 295˙000.00 |
| 6 |
CORIS BIOCONCEPT SPRL
Organization address
address: RUE JEAN SONET 4A PARC SCIENTIFIQUE CREALYS LES ISNES contact info |
BE (Gembloux) | participant | 200˙720.00 |
| 7 |
INSERM - TRANSFERT SA
Organization address
address: Rue Watt 7 contact info |
FR (PARIS) | participant | 200˙497.00 |
| 8 |
BEN-GURION UNIVERSITY OF THE NEGEV
Organization address
address: Office of the President - Main Campus contact info |
IL (BEER SHEVA) | participant | 197˙212.56 |
| 9 |
KATHOLIEKE UNIVERSITEIT LEUVEN
Organization address
address: Oude Markt 13 contact info |
BE (LEUVEN) | participant | 165˙000.00 |
| 10 |
Ministry of Health
Organization address
address: Mithatpasa Cad. 3 contact info |
TR (Sihhiye Ankara) | participant | 155˙775.98 |
| 11 |
NATIONAL HEALTH LABORATORY SERVICES
Organization address
address: MODDERFONTEIN ROAD 1 GAUTENG contact info |
ZA (SANDRINGHAM) | participant | 151˙932.00 |
| 12 |
STATENS VETERINAERMEDICINSKA ANSTALT
Organization address
address: Ulls Vaeg 2B contact info |
SE (UPPSALA) | participant | 124˙484.83 |
| 13 |
UNIVERZA V LJUBLJANI
Organization address
address: KONGRESNI TRG 12 contact info |
SI (LJUBLJANA) | participant | 58˙000.00 |
| 14 |
NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES
Organization address
address: blvd. Yanko Sakazov 26 contact info |
BG (SOFIA) | participant | 57˙999.84 |
| 15 |
"NATIONAL FOUNDATION FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION, INC"
Organization address
address: Park Place Suite 400 55 contact info |
US (ATLANTA GA) | participant | 50˙000.00 |
| 16 |
INSTITUTE OF PUBLIC HEALTH
Organization address
address: ALEKSANDER MOISIU STREET 80 contact info |
AL (TIRANA) | participant | 45˙000.00 |
| 17 |
THE UNIVERSITY OF STIRLING
Organization address
city: STIRLING contact info |
UK (STIRLING) | participant | 26˙619.63 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'Over the last years, large outbreaks of Crimean Congo Hemorrhagic fever virus (CCHFV) in several European countries and neighbouring areas are on the rise. This disease poses a great threat to public health due to its high mortality rate, modes of transmission and geographical distribution. Climate changes and observation of the CCHFV vector in central Europe alarm the European community as we cannot exclude that future outbreaks will take place in non-endemic area of Europe. To date, there is no vaccine available and no selective antiviral drug for the management of the disease. The general knowledge of migration, epidemiology, re-assortment and recombination of the virus is very limited. To fill these gaps, the CCH Fever project proposes to create a multidisciplinary collaborative research environment by bringing together selected competitive advantages such as: operative capacity with appropriate high security research facilities, reference centers and clinical samples from endemic areas and an international network of experienced researchers. This multidisciplinary research consortium will facilitate the progress in several key research areas of the field. This program will mainly focus on (i) developing sensitive and biosafe state-of-art diagnostic tools for CCHFV, (ii) gathering the forces and resources in Europe to build a Biobank of clinical samples, (iii) building a comprehensive database consisting in clinical, laboratory and surveillance data, (iv) taking advantage of unique and state-of art tools to progress towards vaccine candidates and specific antivirals against this bio-threat and (v) disseminating the appropriate knowledge to the health care workers in endemic regions and contributing to capacity building. These achievements will provide tools for local and European public health authorities to prevent or counter future outbreaks and monitor the spread of the disease thanks to the established novel and unique tools and resources.'
Introduzione (Teaser)
Recent outbreaks of Crimean-Congo haemorrhagic fever (CCHF), a tick-borne disease, have alerted health authorities in Europe. The disease's high mortality rates pose a threat to public health and climate changes may facilitate future spread to non-endemic areas.